A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
Clinical trial NCT06378593 · RECRUITING
Trial details
- NCT number
- NCT06378593
- Sponsor
- 3H (Suzhou) Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2028-06-16
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.